Shawn M. Cross's most recent trade in Cyclo Therapeutics Inc - Ordinary Shares - Class A was a trade of 28,597 Common Stock done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics Inc - O... | Shawn M. Cross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 28,597 | 136,346 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc - O... | Shawn M. Cross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 17,228 | 107,749 | - | 0 | Common Stock | |
| Pacira BioSciences Inc | Shawn M. Cross | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Shawn M. Cross | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 75,000 | 75,000 (0%) | 0% | 0 | Common Stock |